United Therapeutics Corp

-1.51 (-0.90%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)7.43B
Current PE14.44
Forward PE 13.07
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$357.61 Million
Adjusted EPS$2.98
See more estimates
10-Day MA$170.43
50-Day MA$162.96
200-Day MA$129.18
See more pivots

United Therapeutics Corp. Stock, NASDAQ:UTHR

1040 Spring Street, Silver Spring, Maryland 20910
United States of America
Phone: +1.301.608.9292
Number of Employees: 920


United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.